Professor emeritus of the Hebrew University of Jerusalem, Israel.
Population and Quantitative geneticist with experience in gene mapping projects. These projects were aimed to detect genes (QTLs) controlling quantitative complex traits.
In recent years, efforts were made to use Deep Sequencing technologies for QTLs detection and biodiversity studies. The detected QTLs were used to produce customized microarrays as tools in breeding programs based on Genomic Selection.
Recently developed sophisticated plans to genetically improve medical cannabis. To the best knowledge, these well approved tools have never been used for cannabis breeding anywhere. Two main target populations are expected to benefit from these activities; pharmaceutical industry and small growers
Marker Assisted Selection (MAS); QTL; DNA markers; Chicken Biodiversity; Type 2 Diabetes Mellitus (T2D); Medical Cannabis; Canabinoids; Metabolites; Marijuana; THC; CBD; CBN; Gender Specific Chromosome; Human Ethnic Biodiversity; Psammomys; Sand Rat; genetic distance; polymorphism; red jungle fowl
Born in Basra, Iraq, 1939. Immigrated to Israel in 1951.
Joined the faculty of agriculture, Hebrew University of Jerusalem in 1973 as a Lecturer in biometrical genetics and breeding; promoted to the positions of senior lecturer, associate professor and full professor in 1978, 1989 and 1992 respectively.
During the years 1978-9, 1985-6, 1992, 1993, 1999 and 2001 spent sabbatical leaves at:
1) ABRO, Edinburgh, Scotland;
2) Leicester, England;
3) Guelph,Canada;
4) VPI, Virginia; and
5-6) Stanford University, USA.
Since 1985, his lab was focused in mapping projects and phylogenetic analyses. During these years, efforts were made to detect QTLs controlling complex traits, using several kinds of molecular markers in various species. In recent years, Deep Sequencing technologies were used for QTLs detection and biodiversity studies. The detected QTLs were used to produce customized microarrays as tools in breeding programs of chickens and turkeys.
In a project on biodiversity of chickens funded by the European Commission (EC), eight laboratories collaborated to assess the genetic variation within and between 52 populations from a wide range of chicken types.
Twenty-two di-nucleotide microsatellite markers were used to genotype DNA pools of 50 birds from each population. The polymorphism measures for the average, the least polymorphic population (inbred C line) and the most polymorphic population (Gallus gallus spadiceus) were, respectively, as follows: number of alleles per locus, per population: 3.5, 1.3 and 5.2; average gene diversity across markers: 0.47, 0.05 and 0.64; and proportion of polymorphic markers: 0.91, 0.25 and 1.0.
These were in good agreement with the breeding history of the populations. For instance, unselected populations were found to be more polymorphic than selected breeds such as layers. Thus DNA pools are effective in the preliminary assessment of genetic variation of populations and markers.
Mean genetic distance indicates the extent to which a given population shares its genetic diversity with that of the whole tested gene pool and is a useful criterion for conservation of diversity.
The distribution of population species (private) alleles and the amount of genetic variation shared among populations supports the hypothesis that the red jungle fowl is the main progenitor of domesticated chicken.
We have discovered a compound (Mir122) which can be used as a medication to treat Type 2 diabetes mellitus (T2DM). The compound including a nucleotides sequence of UGGAGUGUGACAAUGGUGUUUG, for silencing the complementary Messenger RNAs.
We investigated the mode of inheritance of nutritionally induced diabetes in the desert gerbil Psammomys obesus (sand rat), following transfer from low-energy (LE) to high-energy (HE) diet which induces hyperglycaemia. Psammomys selected for high or low blood glucose level were used as two parental lines. A first backcross generation (BC1) was formed by crossing F1 males with females of the diabetes-prone line. The resulting 232 BC1progeny were assessed for blood glucose. All progeny were weaned at 3 weeks of age (week 0), and their weekly assessment of blood glucose levels proceeded until week 9 after weaning, with all progeny maintained on HE diet. At weeks 1 to 9 post weaning, a clear bimodal distribution statistically different from unimodal distribution of blood glucose was observed, normoglycaemic and hyperglycaemic at a 1:1 ratio. This ratio is expected at the first backcross generation for traits controlled by a single dominant gene. From week 0 (prior to the transfer to HE diet) till week 8, the hyperglycaemic individuals were significantly heavier (4–17%) than the normoglycaemic ones. The bimodal blood glucose distribution in BC1generation, with about equal frequencies in each mode, strongly suggests that a single major gene affects the transition from normo- to hyperglycaemia. The wide range of blood glucose values among the hyperglycaemic individuals (180 to 500 mg/dl) indicates that several genes and environmental factors influence the extent of hyperglycaemia. The diabetes-resistant allele appears to be dominant; the estimate for dominance ratio is 0.97.
T2DM is a long term metabolic disorder that is characterized by high blood sugar, insulin resistance, and relative lack or low insulin production. Common symptoms include increased thirst, frequent urination, and unexplained weight loss. Long-term complications from high blood sugar include heart disease, strokes, diabetes retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs which may lead to amputations; all of which can result with premature death.
Mir-122 can be used for diagnostics, prevention and as a therapeutic drug for T2DM in humans. Diagnosis may be applied by identifying individuals carrying the diabetes allele even pre-symptomatically, thus increasing the possibility of prevention through a healthy lifestyle or through medication. Therapeutics may be applied by administrating the pertinence with this innovative compound. Treating may include diagnostics, prevention, and therapy.
T2DM is a chronic metabolic disease. Each year it causes 1.5 million deaths and a further 2.2 million associated with elevated blood glucose. In 1980 there were 108 million cases reported around the world but this had risen to 422 million by 2014, mostly in middle and low income countries. A Harvard study published in April 2016 estimated that the cost of treating and managing the disease was $825 billion per year (https://www.hsph.harvard.edu/news/press-releases/diabetes-cost-825-billion-a- year/)
Biodiversity and phylogeny of worldwide chicken populations. Phylogeny based on Y chromosome-specific microsatellites in man (males) and W-specific in chicken (females). Matrilineal analysis based on mitochondria and W chromosome in chicken. Reconstruction of the Samaritans history.
Genetics and the history of the Samaritans: Y-chromosomal microsatellites and genetic affinity between Samaritans and Cohanim
Human Biology, Volume 85, Number 6, December 2013, pp. 825-857 (Article)
The Samaritans are a group of some 750 indigenous Middle Eastern people, about half of whom live in Holon, a suburb of Tel Aviv, and the other half near Nablus. The Samaritan population numbered is believed to have more than a million in late Roman times, but less than 150 in 1917. The ancestry of the Samaritans has been subject to controversy from late Biblical times to the present. In this study, liquid chromatography-electrospray ionization quadrupole ion trap mass spectrometry was used to allelotype 13 Y-chromosomal and 15 autosomal microsatellites in a sample of 12 Samaritans chosen to have as low a level of relationship as possible, and 461 Jews and non-Jews. Estimation of genetic distances between the Samaritans and seven Jewish and three non-Jewish populations from Israel, as well as populations from Africa, Pakistan, Turkey, and Europe, revealed that the Samaritans were closely related to Cohanim. This result supports the position of the Samaritans that they are descendants from the tribes of Israel dating to before the Assyrian exile in 722–720 BCE. In concordance with previously published single-nucleotide polymorphism haplotypes, each Samaritan family, with the exception of the Samaritan Cohen lineage, was observed to carry a distinctive Y-chromosome short tandem repeat haplotype that was not more than one mutation removed from the six-marker Cohen modal haplotype.
במהלך מאות השנים חיו ערבים בארץ ישראל שהיגרו אליה מאז המאה השבע עשרה מארצות ערב שונות אבל בעיקר מערב הסעודית ומסוריה. אוכלוסיות אלה חיו במסגרות משפחתיות רחבות (חמולות) במסגרות כפריות או כמשפחות מצומצמות. מהגרים אלה התיישבו גם בערים כגון רמאללה, שכם, ג'נין, יריחו, עזה, רפיח, יפו, חיפה, עכו וישובים קטנים באזור ירושלים. אוכלוסיות אלה ממספר דתות, אך בעיקר מוסלמיות, התעבו והתרחבו. הפלסטינים היו אוכלוסיות אך מעולם לא היו עם. עם הוא אוכלוסייה שעברה היסטוריה משותפת למשך דורות רבים. לא ניתן בצורה שרירותית להחליט על קיומו של עם; לא כל אוכלוסייה היא עם.
מאידך, היהודים עברו היסטוריה מגוונת במהלך 3500 השנים האחרונות (כ 150 דורות) עם הרבה מלחמות, חורבנות, הגליות והגירות לארצות רבות ברחבי העולם. אוכלוסיות אלה שמרו על זהותם היהודית גם תחת גזרות שמד אכזריים ומהלכים בל יאומנו של רצח עם. מכאן, היהודים הם אכן עם למרות שרובו לא חי בארץ ישראל. יודגש כי בהגדרות אלה לא צוינה שום זכות יתר לאחד משני הצדדים.